Tromboz, Gemostaz I Reologiya

Тромбоз, гемостаз и реология

Tromboz, Gemostaz I Reologiya
scientific and practical journal

ISSN 2078–1008 (Print); ISSN 2687-1483 (online)

Tromboz, Gemostaz I Reologiya

The journal «Tromboz, gemostaz I Reologiya» was founded in 2001 and is published 4 times per year. «Tromboz, gemostaz I Reologiya» is the official journal of Russian National Association of experts on thrombosis, clinical hemostasiology and hemorheology (www.hemostas.ru).

«Tromboz, gemostaz I Reologiya» is scientific and practical journal publishing reviews, original papers, case reports, etc. Published materials are devoted to diagnostics, therapy and prevention hemocoagulating and hemorheologic disorders owing to inherent or acquired reasons. Main topics are focused to thrombophilias, hemophilias, DIC, venous thromboembolism and thromboses as whole, atherosclerosis and atherothrombosis, platelets and vascular pathology, hemostasis genetics, fibrinolytic system, macro- and microrheologic blood properties, fibrin clot properties, relations between hemostasis system and blood rheology within human body, questions on hemostasis economy. Readers and subscribers have been informed constantly on new books, scientific forums and other professional events, etc.

«Tromboz, gemostaz I Reologiya» is a peer-reviewed journal with 2-years impact factor 0,886 indexed by eLIBRARY.

The journal rates at the SCOPUS database.

The  «TGR» has Q2 rating at Higher Attestation Commission list of periodicals which are recommended for publication of researches for applicants for scientific degrees.

Targetting.

The list of specialties for the journal "Tromboz, Gemostaz I Reologiya» (according to the HAC list dated 26.12.2019 (. pdf)
  • 3.3.3      Pathological physiology
  • 3.1.28    Hematology and Blood transfusion
  • 3.3.8      Clinical Laboratory Diagnostics
  • 3.1.12    Anesthesiology and Intensive Care
  • 3.1.24    Neurology
  • 3.1.4      Obstetrics and Gynecology
  • 3.1.6      Oncology, Radiation therapy
  • 3.1.20    Cardiology
  • 3.3.6      Pharmacology, Clinical Pharmacology
  • 3.1.27    Rheumatology
  • 3.1.8      Traumatology and Orthopedics
  • 3.1.21    Pediatrics

Main charts (Sections)

  • Original papers,
  • Clinical cases,
  • Lectures,
  • Reviews,
  • Professional news.

Options

Before publishing all materials have mandatory peer review.
For authors publications are free of charge.
The journal is citied by VINITI à The journal is cited VINITI.

The journal is included in the Russian index of Scientific Citation

Webpage: http://elibrary.ru/title_about.asp?id=26078 
Values (as per 2018)

The two-year impact factor = 0,543
The two-year impact factor with regard to the citation from all sources = 0,814
Ten-year h-index = 13,0

General information

  • Layout A4
  • Volume 80 pages
  • Quaterly
  • 1500 copies

Subscription

  • Per the editorial office
  • Per «Pressa Rossii» agency
    • 83835 - individual
    • 83837 - legal entities
  • Per JSC Russian Post
    • П18362 - individual
    • П18363 - legal entities
  • Per «Ural-Press» cataloque
    • 18362 - individual
    • 18363 - legal entities
  • Per alternative agencies catalogs

Distribution

Via mailing address.
Distribution at forums and exhibitions

The journal «Tromboz, gemostaz I Reologiya» registered by Federal service on supervision of legislation observance in sphere of mass communications and cultural heritage protection (August 24th, 2001; PI No. 779636).

The Editorial Board is not responsible for the content of advertisements. Under a reprint of materials the reference to the journal «Tromboz, gemostaz I Reologiya» is mandatory required.

 

Creative Commons License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License

Review

Marina A. Ovchinnikova, Vladimir S. Vlasov, Zoya V. Dyakonenko, Nikolay N. Osipov, Dmitry M. Spelnikov, Alexander B. Belevitin, Tatiana V. Vavilova
Predictive risk scales for venous thromboembolism in outpatients with solid tumors
Ivan R. Galak, Namzhil N. Tsybikov, Andrey N. Mamaev, Andrey P. Momot
Diversity of fibrin stabilizing blood coagulation factor substrates
Marine M. Tanashyan, Eugene V. Roitman, Anton A. Raskurazhev, Polina I. Kuznetsova, Andrey S. Mazur
Thrombotic risk markers: thrombin-antithrombin complex
Elaf Shaaban Ibrahim, Lelas Farhan Bdaiwi, Safaa Jassim Mohammed, Yusur Farhan Bdaiwi
Thalassemia, vitamin D3 deficiency, and serum ferritin as a prognostic marker: a review

Original papers

Aleksei A. Surenkov, Elena V. Yakovleva, Elena B. Orel, Valentina N. Dvirnyk, Nadezhda I. Zozulya
Acquired hemophilia as an obstetric and interdisciplinary challenge
Dmitry A. Momot, Andrey N. Mamaev, Mikhail I. Neimark, Dmitry V. Fedorov, Igor I. Shakhmatov, Galina G. Belozerskaya, Andrey P. Momot
Tissue factor, D-dimer, and other participants and markers of hemocoagulation at the crossroad of coagulation and fibrinolysis pathways in severe COVID-19
Evgeny B. Zhiburt, Ramil G. Khamitov, Evgeny A. Shestakov, Sergey R. Madzaev, Oksana V. Fedyk, Leonid D. Shalygin
Transfusion for hemostasis management in clinical guidelines “Acute promyelocytic leukemia”
Maria V. Khimina, Olga V. Sirotkina, Tatiana L. Karonova, Arina A. Mikhailova, Tatiana V. Vavilova
Morphology of red blood cells in long-COVID-patients
Yury I. Buziashvili, Inga V. Tetvadze, Lana N. Kirtbaia
Endothelial dysfunction parameters in the prognosis of cardiovascular complications after percutaneous coronary interventions
Eugene V. Roitman, Alla A. Shabalina, Marine M. Tanashyan, Nataliya Yu. Dmitrieva
Comparison of conventional and automated thromboelastography

Clinical cases

Vladislav A. Annushkin, Olga V. Lagoda, Alla A. Shabalina
Hemostasis disorders and cryptogenic ischemic stroke in young women: clinical cases
View All Issues